Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue.

[1]  K. Takano,et al.  Serum adiponectin levels in adult growth hormone deficiency and acromegaly. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[2]  S. Tam,et al.  Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. , 2004, The Journal of clinical endocrinology and metabolism.

[3]  E. Ravussin,et al.  Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes , 2004, Diabetologia.

[4]  R. Paschke,et al.  Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3‐L1 adipocytes , 2004 .

[5]  A. Luger,et al.  Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo , 1985, Diabetologia.

[6]  R. Landgraf,et al.  Prolactin: A diabetogenic hormone , 1977, Diabetologia.

[7]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.

[8]  D. Eizirik,et al.  Expression of adiponectin receptors in pancreatic beta cells. , 2003, Biochemical and biophysical research communications.

[9]  F. Karlsson,et al.  Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. , 2003, The Journal of clinical endocrinology and metabolism.

[10]  E. Sivan,et al.  Free fatty acids, insulin resistance, and pregnancy , 2003, Current diabetes reports.

[11]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[12]  V. Hána,et al.  Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance , 2003, Clinical endocrinology.

[13]  E. Laurila,et al.  Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  C. Ling,et al.  Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. , 2003, The Journal of clinical endocrinology and metabolism.

[15]  J. Knapp,et al.  Enlargement of Interscapular Brown Adipose Tissue in Growth Hormone Antagonist Transgenic and in Growth Hormone Receptor Gene-Disrupted Dwarf Mice , 2003, Experimental biology and medicine.

[16]  P. Iyengar,et al.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. , 2003, Diabetes.

[17]  P. Kelly,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance , 2022 .

[18]  M. Bohlooly-y,et al.  Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. , 2001, American journal of physiology. Endocrinology and metabolism.

[19]  C. Ling,et al.  PRL Receptor-Mediated Effects in Female Mouse Adipocytes: PRL Induces Suppressors of Cytokine Signaling Expression and Suppresses Insulin-Induced Leptin Production in Adipocytes in Vitro. , 2001, Endocrinology.

[20]  M. Bohlooly-y,et al.  Vascular Function and Blood Pressure in GH Transgenic Mice. , 2001, Endocrinology.

[21]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[22]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[23]  J. Kopchick,et al.  Growth hormone receptor/binding protein (GHR/BP) knockout mice: a 3-year update. , 2001, Molecular genetics and metabolism.

[24]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[25]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Ling,et al.  Prolactin (PRL) Receptor Gene Expression in Mouse Adipose Tissue: Increases during Lactation and in PRL-Transgenic Mice. , 2000, Endocrinology.

[27]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[29]  J. Kopchick,et al.  Transgenic models of growth hormone action. , 1999, Annual review of nutrition.

[30]  T. Wagner,et al.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  O. Isaksson,et al.  Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. , 1998, Endocrinology.

[32]  P. Kelly,et al.  Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. , 1997, Genes & development.

[33]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[34]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[35]  B. Bengtsson,et al.  Growth hormone-deficient adults are insulin-resistant. , 1995, Metabolism: clinical and experimental.

[36]  T. Saleem,et al.  The effect of prolactin and relaxin on insulin binding by adipocytes from pregnant women. , 1984, American journal of obstetrics and gynecology.

[37]  S. Röjdmark,et al.  Does acute endogenous hyperprolactinemia affect intravenous glucose tolerance in humans? , 1984, Metabolism: clinical and experimental.

[38]  P. Sönksen,et al.  Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. , 1967, The Journal of clinical endocrinology and metabolism.